1winRussia

The management of Mucopolysaccharidosis type VI (MPS VI) necessitates a multifaceted approach. One of the primary therapies involves the enzyme replacement treatment, galsulfase. Understanding its efficacy is critical for pediatric care. MPS VI, a lysosomal storage disorder, results in the accumulation of dermatan sulfate. This accumulation causes significant systemic complications. Mechanism of Action of Galsulfase […]